Clinical analysis of laparoscopic D2 lymphadenectomy for distal gastric cancer.
- Author:
Jun XU
1
;
Yong-hong DONG
;
Bao-yu ZHAO
;
Wei DING
;
Zhi CHEN
;
Shu-sheng WU
Author Information
- Publication Type:Journal Article
- MeSH: Colon, Transverse; Gastrectomy; Humans; Laparoscopy; Length of Stay; Lymph Node Excision; Lymph Nodes; Mesocolon; Pancreas; Stomach Neoplasms; surgery
- From: Chinese Journal of Gastrointestinal Surgery 2012;15(12):1269-1272
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVESTo investigate the surgical approach, feasibility and surgical outcomes of laparascopic distal gastrectomy D2(LDGD2).
METHODSFifty-four patients who underwent LDGD2 were examined in terms of pathologic findings, operative outcomes, and complications. A simple and effective surgical procedure was as follows: gastrocolic ligament--transverse mesocolon anterior lobe--pancreatic capsule--4sb--4d--6--14v, 8a--12a--9--7--11p, 1--3--5--lesser omental bursa. Efficacy and feasibility of this procedure was analyzed.
RESULTSThe mean operative time was (236±51) minutes, the mean number of lymph nodes was(18±5), the mean positive lymph nodes were 0-14, the mean blood loss was(217±65) ml, and postoperative mean hospital stay was(15±4) days.
CONCLUSIONSLDGD2 for lower and lower-middle gastric cancer is feasible and safe, and can meet the oncological demand.
